Frank Lammert

Active 1999–2026

174
Papers
24,209
Citations
92
h-index
170
i10-index

Citations

Citations per year for Frank Lammert1994: 3 citations1996: 2 citations1997: 1 citations1999: 1 citations2000: 6 citations2001: 11 citations2002: 29 citations2003: 35 citations2004: 55 citations2005: 94 citations2006: 112 citations2007: 117 citations2008: 131 citations2009: 121 citations2010: 157 citations2011: 152 citations2012: 138 citations2013: 197 citations2014: 196 citations2015: 213 citations2016: 211 citations2017: 186 citations2018: 211 citations2019: 671 citations2020: 826 citations2021: 1,022 citations2022: 856 citations2023: 660 citations2024: 1,111 citations2025: 504 citations2026: 20 citations1995: no citations, so this year is not shown1998: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,314 citing papers, 19.6% of this breakdownChina: 1,136 citing papers, 9.6% of this breakdownGermany: 983 citing papers, 8.3% of this breakdownUnited Kingdom: 821 citing papers, 6.9% of this breakdownItaly: 736 citing papers, 6.2% of this breakdownSpain: 466 citing papers, 3.9% of this breakdownFrance: 407 citing papers, 3.4% of this breakdownNetherlands: 323 citing papers, 2.7% of this breakdownSwitzerland: 302 citing papers, 2.6% of this breakdownCanada: 293 citing papers, 2.5% of this breakdownAustria: 259 citing papers, 2.2% of this breakdownJapan: 258 citing papers, 2.2% of this breakdown
0%19.6%Other 29.9%

Fields

  • Medicine76.6%
  • Biochemistry, Genetics and Molecular Biology15.1%
  • Immunology and Microbiology2.4%
  • Pharmacology, Toxicology and Pharmaceutics2%
  • Neuroscience1.1%
  • Agricultural and Biological Sciences0.8%
  • Other2%

Topics

  • Liver Disease Diagnosis and Treatment12.7%
  • Liver Disease and Transplantation5.2%
  • Drug Transport and Resistance Mechanisms3.8%
  • Liver Diseases and Immunity3.4%
  • Hepatitis C virus research2.8%
  • Gallbladder and Bile Duct Disorders2.4%
  • Other69.7%

Coauthors

All papers

Open in search
  1. Gallstones

    Authors: , , , , , , , , - Nature Reviews Disease Primers 2016 cited by 862

  2. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John Bate, Mark Danta, Jacob George, Alexander Hodge, Nickolas Kontorinis, S.A. Roberts, Santosh Sanagapalli, Richard Skoien, Alexander Thompson, Amany Zekry, Rudolf Stauber, Michael Trauner, Christophe Moreno, Hendrik Reynaert, Len Verbeke, Mário Reis Álvares‐da‐Silva, Edison Roberto Parise, Cláudia P. Oliveira, Roberta Chaves Araújo, Ana de Lourdes Candolo Martinelli, Meredith A. Borman, Natasha Chandok, Magdy Elkhashab, Hughie F. Fraser, Kelly Kaita, Mang Ma, Paul Marotta, Alnoor Ramji, Edward Tam, Eric M. Yoshida, Mark G. Swain, Giada Sebastiani, Denis Petrunia, Armand Abergel, Rodolphe Anty, Marc Bourlière, Jérôme Boursier, Christophe Bureau, Laurent Castéra, François Habersetzer, Christophe Hézode, V. de Lédinghen, Vincent Leroy, V. Loustaud‐Ratti, Philippe Mathurin, Stanislas Pol, Fabien Zoulim, Holger Hinrichsen, Patrick Ingiliz, Frank Lammert, Michael Manns, Jörn M. Schattenberg, Ingolf Schiefke, Christian Trautwein, Stefan Zeuzem, Aric J. Hui, K Li, Vincent Wai‐Sun Wong, Subrat Kumar Acharya, Abhijit Chowdhury, Ajay Duseja, Dharmesh Kapoor, Shrikant Mukewar, Shiv Kumar Sarin, Samir Shah, S. Shalimar, Ajit Sood, BV Tantry, Ziv Ben‐Ari, Helena Katchman and 540 more - Journal of Hepatology 2020 cited by 466

  3. Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population

    Authors: , , , , , , , , , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2021 cited by 276

  4. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eva Bonfill, Marta Juan, Anna Sòria, Marta Carol, Jordi Gratacós‐Ginès, Rosa M. Morillas, Pere Torán‐Monserrat, J. M. Navarrete, Antoni Torrejón, Céline Fournier, Anne Llorca, Anita Arslanow, Harry J de Koning, Fernando Cucchietti, Michael P. Manns, Philip N. Newsome, Rubén Hernáez, Alina M. Allen, Paolo Angeli, Robert J. de Knegt, Tom H. Karlsen, Peter R. Galle, Vincent Wai‐Sun Wong, Núria Fabrellas, Laurent Castéra, Aleksander Krag, Frank Lammert, Patrick S Kamath, Pere Ginès, Marifé Alvarez, Peter Andersen, Paolo Angeli, Alba Ardèvol, Anita Arslanow, Luca Beggiato, Zahia Ben Abdesselam, Lucy Bennett, Bajiha Boutouria, Alessandra Brocca, M. Teresa Broquetas, M. Teresa Broquetas, Valeria Calvino, Judith Camacho, Aura Capdevila, Marta Carol, Laurent Castéra, Marta Cervera, Marta Cervera, Anna de Fuentes, Rob de Knegt, Rob de Knegt, Sönke Detlefsen, Alba Díaz, José Diéguez Bande, Vanessa Esnault, Núria Fabrellas, Josep Lluis Falcó, Rosa Fernández, Céline Fournier, Céline Fournier, Peter R. Galle, Edgar García, Montserrat Garcı́a-Retortillo, E.A González Garrido, Pere Ginès, Rosa Gordillo Medina, Jordi Gratacós‐Ginès, Isabel Graupera, Jordi Gratacós-Ginès, Indra Neil Guha and 78 more - The Lancet 2023 cited by 157

  5. Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Hepatology 2021 cited by 289

  6. Global multi-stakeholder endorsement of the MAFLD definition

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Manuel Romero‐Gomez, Mohammed Eslam, Maria Lorena Abate, Bahaa Abbas, Ahmed Amr Abbassy, Waleed Abd El Ghany, Amira Abd Elkhalek, Emad Abd ElMajeed, Mohammad Abdalgaber, Mohamed AbdAllah, Marwa Abdallah, Nourhan Abdallah, Shereen Abdelaleem, Yasser Abdelghani, Wael Abdelghany, Safaa Mohamed Abdelhalim, Wafaa Abdelhamid, Nehal Abdelhamid, Nadia A. Abdelkader, Elsayed Abdelkreem, Aly Mohamed Abdelmohsen, Awny Ali Abdelrahman, Sherief M Abd-elsalam, Doaa Abdeltawab, Abdulbaset Abduh, Nada Abdulhakam, Maheeba Abdulla, Navid Abedpoor, Ludovico Abenavoli, Fredrik Åberg, Omala Ablack, Mostafa Abo elftouh, Yousry Esam-Eldin Abo-Amer, Ashraf Aboubkr, Alaa Aboud, Amr M. Abouelnaga, Galal A. Aboufarrag, Ashraf Aboutaleb, Leticia Abundis, Gupse Adalı, Enrique Adames, Leon Adams, Danjuma Adda, Noor Adel, Nada Adel, Muhammad Adel Sayed, Taiba Jibril Afaa, Nawal Afredj, Gulnara Aghayeva, Alessio Aghemo, Carlos A. Aguilar-Salinas, Golo Ahlenstiel, Walid Ahmady, Wafaa Ahmed, Amira Ahmed, Samah Nasser Ahmed, Heba Mostafa Ahmed, Rasha Ahmed, Elmar Aigner, Mesut Akarsu, Maisam Akroush, Umit Akyuz, Mamun Al Mahtab, Tahani Al Qadiri, Yusriya Al Rawahi, Razzaq AL rubaee, Muna Al Saffar, Shahinul Alam, Zaid Al-Ani, Agustín Albillos and 957 more - ˜The œLancet. Gastroenterology & hepatology 2022 cited by 223

  7. A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pierre Deltenre, Henry Völzke, Markus M. Lerch, Julia Mayerle, Florian Eyer, Clemens Schafmayer, Sven Cichon, Markus M. Nöthen, Michael Nothnagel, David Ellinghaus, Klaus Huse, André Franke, Steffen Zopf, Claus Hellerbrand, Christophe Moreno, Denis Franchimont, Marsha Y. Morgan, Jochen Hampe - Nature Genetics 2015 cited by 559

  8. Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Schmelz Heimerl, Anna-Magdalena Stephan, Christiane Fibbe, Niels Liedtke, Jutta Keller, Ulrich Rosien, Sebastian Haag, A Schneider, Dirk Hartmann, Christoph Schmöcker, Hendrik Buchholz, Frank Lammert, Markus Casper, Matthias Reichert, Ahmed Madisch, D. Sommer, Hubert Mönnikes, Miriam Stengel, M. Schmidtmann, Michaela Müller, Alexander J. Eckardt, Till Wehrmann, Stefan Schubert, Peter Armerding, Wolf Peter Hofmann, Thomas Liceni, Ulrike von Arnim, Arne Kandulski, Jochen Weigt, Norbert Börner, A. Lutz-Vorderbrügge, Jörg Albert, Stefan Zeuzem, Irina Blumenstein, Kathrin Sprinzl, Johannes Hausmann, Arjan Bredenoord, Arjan Bredenoord, Marijn J. Warners, Alfredo Lucendo Villarin, Ángel Arias, Maria Ángeles Tejero Bustos, María Jesús Carrillo Ramos, J.M. Gallardo, Rocío Juárez Tosina, Javier Molina‐Infante, José Luis Zamorano, Cecilio Santander Vaquero, Sergio Casabona, Maria T. Perez, Teresa Rodríguez, Constanza Ciriza de los Ríos, Fernando Canga Rodríguez‐Valcárcel, Isabel Castel de Lucas, Antonia Perelló Juan, Mercè Barenys, Carlos Pons, Isabel Pérez‐Martínez, M. Eugenia Lauret, Andrés Castaño García, Esmeralda Rubio, Alex Straumann, Petr Hrúz, Simon Brunner, Jamal Hayat, Andrew Poullis - Gastroenterology 2019 cited by 294

  9. Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2014 cited by 898

  10. Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Hepatology 2017 cited by 285

  11. Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stefan Schubert, Ulrike von Arnim, Norbert Börner, Dieter Witzemann, Karel Caca, Jörg Albert, Stefan Zeuzem, Felix Wiedbrauck, Helmut Messmann, Albert J. Bredenoord, Robert C. Verdonk, Franciscus Wolfhagen, Alfredo Lucendo Villarin, Cecilio Santander Vaquero, Constanza Ciriza de los Ríos, Antonia Perelló Juan, Isabel Pérez‐Martínez, Joaquín Rodríguez Sánchez-Migallón, Jésus Barrio, ÁngelesPérez Aisa, Alex Straumann, Petr Hrúz, Alain Schoepfer, Luc Biedermann, Jamal Hayat, Anjan Dhar - Gastroenterology 2020 cited by 206

  12. Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: A multicenter randomized trial (GRAFT study)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2021 cited by 140

  13. rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , M. Dabbas, Déirdre Kelly, Valério Nobili, Connor A. Emdin, Madison Fairey, Glenn S. Gerhard, Guðný Eiríksdóttir, Melissa E. Garcia, Vilmundur Guðnason, Tamara B. Harris, Lauren J. Kim, Lenore J. Launer, Michael A. Nalls, Albert V. Smith, Jeanne M. Clark, Rubén Hernáez, Wei-Tang Kao, Braxton D. Mitchell, Alan R. Shuldiner, Laura M. Yerges‐Armstrong, Ingrid B. Borecki, J. Jeffrey Carr, Mary F. Feitosa, Jun Wu, Johannah L. Butler, Caroline S. Fox, Joel N. Hirschhorn, Udo Hoffmann, Shih‐Jen Hwang, Joseph M. Massaro, Christopher J. O’Donnell, Cameron D. Palmer, Dushyant V. Sahani, Elizabeth K. Speliotes, Xiuqing Guo, Jochen Hampe, Matthew Hickman, Lena Heintz, Christian Hudert, Harriet Hunter, Matt Kelly, Julia Kozlitina, Marcin Krawczyk, Frank Lammert, Claudia Langenberg, Joel E. Lavine, Lin Li, Hong Kai Lim, Rohit Loomba, Panu K. Luukkonen, Phillip E. Melton, Trevor A. Mori, Nicholette D. Palmer, Constantinos A. Parisinos, Sreekumar Pillai, Faiza Qayyum, Matthias Reichert, Stefano Romeo, Jerome I. Rotter, Yu Ri Im, Nicola Santoro, Clemens Schafmayer, Elizabeth K. Speliotes, Stefan Stender, Felix Stickel, Christopher D. Still, Pavel Strnad, Kent D. Taylor, Anne Tybjærg‐Hansen, Giuseppina Rosaria Umano and 10 more - Journal of Hepatology 2020 cited by 137

  14. European Guideline on IgG4‐related digestive disease – UEG and SGF evidence‐based recommendations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexander Schneider, Eric F.H. van Bommel, Caroline S. Verbeke, Marie‐Pierre Vullierme, Heiko Witt, the UEG guideline working group - United European Gastroenterology Journal 2020 cited by 238

  15. A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2023 cited by 92

  16. The Treatment of Gallstone Disease

    Authors: , , - Deutsches Ärzteblatt international 2020 cited by 200

  17. The Role of Diet in the Pathogenesis of Cholesterol Gallstones

    Authors: , , , , , , , - Current Medicinal Chemistry 2017 cited by 191

  18. The Collaborative Cross, a community resource for the genetic analysis of complex traits

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Doug Matthews, Melloni N. Cook, Roger Cox, John C. Crabbe, Wim E. Crusio, Ariel Darvasi, Christian F. Deschepper, Bastien Llamas, R. W. Doerge, Charles R. Farber, Juan F. Medrano, Jiřı́ Forejt, Daniel P. Gaile, Steven J. Garlow, Hartmut Geiger, Howard K. Gershenfeld, Terry Gordon, Weikuan Gu, Gerald de Haan, Richard S. Nowakowski, Nancy L. Hayes, Craig Heller, Heinz Himmelbauer, Kent W. Hunter, Hui-Chen Hsu, Fuad A. Iraqi, Boris Ivandic, Howard J. Jacob, Ritsert C. Jansen, Karl J. Jepsen, Dabney K. Johnson, Gerd Kempermann, Christina Kendziorski, Malak Kotb, R. Frank Kooy, Frank Lammert, Jean‐Michel Lassalle, Pedro R. Löwenstein, Aldons J. Lusis, Kenneth F. Manly, Ralph Marcucio, Darla R. Miller, Beverly A. Mock, Jeffrey S. Mogil, Xavier Montagutelli, Grant Morahan, D.G. Morris, Richard Mott, William Valdar, Joseph H. Nadeau, Hiroki Nagase, Bruce F. O’Hara, А. В. Осадчук, Nengjun Yi, Grier P. Page, Abraham A. Palmer, Leena Peltonen-Palotie, Daniel Pomp, Daniel Pomp, Michal Pravenec, Daniel R. Prows, Zhonghua Qi, Roger H. Reeves, John Roder, Glenn D. Rosen, Eric E. Schadt, Leonard C. Schalkwyk, Ze’ev Seltzer, Kazuhiro Shimomura, Siming Shou and 13 more - Nature Genetics 2004 cited by 1,193

  19. Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group

    Authors: , , , , , , , , , , , , , , , , , , , - JHEP Reports 2019 cited by 99

  20. Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis

    Authors: , , , , , , , , , - Journal of Hepatology 2012 cited by 322

  21. Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis

    Authors: , , , , , , , , , , , , , , - JAMA 2012 cited by 1,502

  22. Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2019 cited by 160

  23. Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christoph Antoni, Gerhard Klausmann, Dieter Häussinger, Alexander Zipprich - ˜The œLancet. Gastroenterology & hepatology 2019 cited by 82

  24. Screening for liver fibrosis: lessons from colorectal and lung cancer screening

    Authors: , , , , , , , - Nature Reviews Gastroenterology & Hepatology 2024 cited by 23